ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,330Medicare Part D Prescriptions Filled, Including Refills

Rank: 847 out of 3647

$546K Total Retail Price of All Prescriptions

Rank: 945 out of 3647

434 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 434 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 434 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 8,289 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
AMLODIPINE BESYLATE 405 352 1 2
LEVOTHYROXINE SODIUM 389 345 2 5
HYDROCODONE-ACETAMINOPHEN 345 270 S3 3 12
LISINOPRIL 285 227 4 4
SIMVASTATIN 273 240 5 1
FUROSEMIDE 252 220 6 8
OMEPRAZOLE 245 190 7 3
METFORMIN HCL 213 147 8 6
METOPROLOL SUCCINATE 209 162 9 18
LOSARTAN POTASSIUM 179 161 10 11
METOPROLOL TARTRATE 174 150 11 7
PRAVASTATIN SODIUM 174 130 11 16
TRAMADOL HCL 163 98 13 22
HYDROCHLOROTHIAZIDE 157 139 14 9
LOSARTAN-HYDROCHLOROTHIAZIDE 155 144 15 48
TRAZODONE HCL 153 132 16 64
CRESTOR 145 96 17 19
KLOR-CON M20 141 120 18 121
POTASSIUM CHLORIDE 134 129 19 24
ATORVASTATIN CALCIUM 124 91 20 13
ALENDRONATE SODIUM 121 104 21 23
WARFARIN SODIUM 114 104 22 15
PANTOPRAZOLE SODIUM 109 96 23 38
DONEPEZIL HCL 108 107 24 30
FENOFIBRATE 103 92 25 50
GABAPENTIN 92 61 26 17
CITALOPRAM HBR 88 68 27 25
GLIMEPIRIDE 84 43 28 45
ATENOLOL 80 77 29 10
CYCLOBENZAPRINE HCL 79 27 R 30 98
PLAVIX 77 54 31 39
CLONIDINE HCL 77 56 31 46
SYNTHROID 75 56 33 42
RANITIDINE HCL 74 68 34 29
CLOPIDOGREL 73 42 35 26
TAMSULOSIN HCL 72 51 36 28
ISOSORBIDE MONONITRATE ER 72 72 36 56
CARVEDILOL 70 68 38 20
SERTRALINE HCL 69 49 39 27
ZOLPIDEM TARTRATE 66 45 40 14
CYMBALTA 61 46 41 79
SPIRIVA 61 34 41 93
TRIAMTERENE-HCTZ 59 48 43 58
PAROXETINE HCL 58 58 44 60
AMITRIPTYLINE HCL 58 36 R 44 105
NEXIUM 57 39 46 44
BYSTOLIC 53 53 47 158
KLOR-CON 10 51 36 48 106
DIOVAN 50 46 49 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 15, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.